Afzal Qasim, Muneer Hussain Siddiqui, Muhammad Tanveer Alam


Stable angina is one of the main manifestations of coronary artery disease. The presence of angina symptoms, a positive exercise test for myocardial ischaemia and confirmation of coronary artery atherosclerosis by coro¬nary angiography are the bases of diagnosis of chronic stable angina. Present research however has yet not completely determined the helpfulness of invasive treatment of the coronary arteries with percutaneous coronary intervention in comparison with medication. Percutaneous coronary intervention is recognized to reduce the incidence of death and myocardial infarction in patients who suffer from acute coronary syndrome, the same benefit however does not appear to extend to patients who have stable coronary artery disease. Although some studies have shown improvement in survival for the patients with stable angina undergoing PCI but most have shown that PCI does not show any improvement in mortality or risk of myocardial infarction in these patients.


Percutaneous coronary intervention; Angina; Myocardial infarction.

Full Text:



Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part 1: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001: 104:2746-53.

Opie LH, Commerfold PJ, Gersh BJ. Controversies in stable coronary artery disease. Lancet 2006; 367: 69-78.

Abrams J. Clinical practice: chronic stable angina. N Engl J Med 2005; 352:2524-33.

Vaina S, Stefanadis C. Treatment of multi-vessel coronary artery disease. What is the optimal revascularisation approach? What do we know, what will we learn? Hellenic J Cardiol 2007; 48: 1-4.

Mehta SR, Cannon CP, Fox KAA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005; 293:2908-17.

Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease.Veterans Affairs ACME Investigators. N Engl J Med 1992; 326: 10-16.

Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME Investigators. J Am Coll Cardiol 1997; 29:1505-11.

Pepine CJ, Sharaf B, Andrews TC, et al. Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at one year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group. J Am Coll Cardiol 1997; 29: 1483-91.

Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997; 95:2037-43.

Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators. N Engl J Med 1999; 341:70-77.

Hueb WA, Soares PR, Almeida De Oliveira S, et al. Five year follow-up of the medicine, angioplasty, or surgery study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation1999; 100: I107-13.

Zeymer U, Uebis R, Vogt A, et al. Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte. Circulation.2003; 108:1324-28.

Henderson RA, Pocock SJ, Clayton TC, et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003; 42:1161-70.

Rita-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997; 350: 461-8.

Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation2004; 110:1213-8.

Kaiser C, Kuster GM, Erne P, et al. Risks and benefits of optimized medical and revascularisation therapy in elderly patients with angina - on-treatment analysis of the TIME trial. Eur Heart J 2004; 25:1036-42.

Pfisterer M, Buser P, Osswald S, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: oneyearresults of the randomized TIME trial. JAMA 2003; 289:1117-23.

Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomized trial. Lancet 2001; 358: 951-7.

Hambrecht R, Walther C, Möbius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation.2004; 109: 1371-1378.

Madsen JK, Nielsen TT, Grande P, et al. Revascularization compared to medical treatment in patients with silent vs. symptomatic residual ischemia after thrombolyzed myocardial infarction-the DANAMI study. Cardiology 2007; 108: 243-51.

Mahmarian JJ, Dakik HA, Filipchuk NG, et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol 2006; 48: 2458-67.

Soares PR, Hueb WA, Lemos PA, et al. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multi vessel disease: an analysis from the Medicine,Angioplasty, or Surgery Study (MASS II). Circulation 2006;114: I420-4.

Hueb W, Soares PR, Gersh BJ, et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am CollCardiol2004; 43: 1743-51.

Hueb W, Lopes N, Gersch B, et al. Five year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007;115: 1082-9.

Daemen J, Boersma E, Flather M, et al. Long term safety and efficacy of percutaneous intervention with stenting andcoronary artery bypass Surgery for Multivessel Coronary Artery Disease. Ametanalysis with a 5-year patient-level datafrom the ARTS, ERACI II, MASS II and SOS trials. Circulation2008; 118: 1146-54.

Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 2007; 297: 1985-91.

Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-16.

Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI onquality of life in patients with stable coronary disease. N Engl J Med 2008; 359: 677-87.

Gu Y, Hu Y, Hu L, Cheng Z, Li L. Outcome of patients withstable angina pectoris treated with or without percutaneouscoronary intervention. Cardiol J 2008; 15: 226-9.

Schömig A, Mehilli J, de Waha A, Seyfarth M, Pache J, Kastrati A. A meta-analysis of 17 randomized trials of a percutaneouscoronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 894-904.

Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous coronary interventions for nonacute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet 2009; 373: 911-8.

Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-anal¬ysis. Circulation 2005; 111: 2906-12.

Coylewright M, Blumenthal RS, Post W. Placing COURAGE in context: review of the recent literature on managing stable coronary artery disease. Mayo Clin Proc 2008; 83:799-805.


  • There are currently no refbacks.

Copyright (c) 2020 Afzal Qasim, Muneer Hussain Siddiqui, Muhammad Tanveer Alam

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.